252 related articles for article (PubMed ID: 33278129)
1. Advances in the management of statin myopathy.
Gallo A; Perregaux J; Bruckert E
Curr Opin Endocrinol Diabetes Obes; 2021 Apr; 28(2):142-151. PubMed ID: 33278129
[TBL] [Abstract][Full Text] [Related]
2. Optimizing Cholesterol Treatment in Patients With Muscle Complaints.
Rosenson RS; Baker S; Banach M; Borow KM; Braun LT; Bruckert E; Brunham LR; Catapano AL; Elam MB; Mancini GBJ; Moriarty PM; Morris PB; Muntner P; Ray KK; Stroes ES; Taylor BA; Taylor VH; Watts GF; Thompson PD
J Am Coll Cardiol; 2017 Sep; 70(10):1290-1301. PubMed ID: 28859793
[TBL] [Abstract][Full Text] [Related]
3. Statin associated muscle symptoms (SAMS): strategies for prevention, assessment and management.
Iatan I; Mancini GBJ; Yeoh E; Hegele RA
Expert Rev Cardiovasc Ther; 2023 Jun; 21(6):423-435. PubMed ID: 37212306
[TBL] [Abstract][Full Text] [Related]
4. Suggested clinical approach for the diagnosis and management of 'statin intolerance' with an emphasis on muscle-related side-effects.
Sivashanmugarajah A; Fulcher J; Sullivan D; Elam M; Jenkins A; Keech A
Intern Med J; 2019 Sep; 49(9):1081-1091. PubMed ID: 31507054
[TBL] [Abstract][Full Text] [Related]
5. Risk factors and drug interactions predisposing to statin-induced myopathy: implications for risk assessment, prevention and treatment.
Chatzizisis YS; Koskinas KC; Misirli G; Vaklavas C; Hatzitolios A; Giannoglou GD
Drug Saf; 2010 Mar; 33(3):171-87. PubMed ID: 20158283
[TBL] [Abstract][Full Text] [Related]
6. Management of the patient with statin intolerance.
Vandenberg BF; Robinson J
Curr Atheroscler Rep; 2010 Jan; 12(1):48-57. PubMed ID: 20425271
[TBL] [Abstract][Full Text] [Related]
7. Statin intolerance: new data and further options for treatment.
Diaconu CC; Iorga RA; Furtunescu F; Katsiki N; Stoian AP; Rizzo M
Curr Opin Cardiol; 2021 Jul; 36(4):487-493. PubMed ID: 33929368
[TBL] [Abstract][Full Text] [Related]
8. Statin myopathy: over-rated and under-treated?
Maghsoodi N; Wierzbicki AS
Curr Opin Cardiol; 2016 Jul; 31(4):417-25. PubMed ID: 27258372
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of bempedoic acid in patients not receiving statins in phase 3 clinical trials.
Laufs U; Ballantyne CM; Banach M; Bays H; Catapano AL; Duell PB; Goldberg AC; Gotto AM; Leiter LA; Ray KK; Bloedon LT; MacDougall D; Zhang Y; Mancini GBJ
J Clin Lipidol; 2022; 16(3):286-297. PubMed ID: 35346603
[TBL] [Abstract][Full Text] [Related]
10. Management of Statin Intolerance in 2018: Still More Questions Than Answers.
Toth PP; Patti AM; Giglio RV; Nikolic D; Castellino G; Rizzo M; Banach M
Am J Cardiovasc Drugs; 2018 Jun; 18(3):157-173. PubMed ID: 29318532
[TBL] [Abstract][Full Text] [Related]
11. Expert opinion: the therapeutic challenges faced by statin intolerance.
Patel J; Martin SS; Banach M
Expert Opin Pharmacother; 2016 Aug; 17(11):1497-507. PubMed ID: 27254275
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis and Management of Statin Intolerance.
Alonso R; Cuevas A; Cafferata A
J Atheroscler Thromb; 2019 Mar; 26(3):207-215. PubMed ID: 30662020
[TBL] [Abstract][Full Text] [Related]
13. [Statin intolerance].
Graversen CB; Larsen ML; Schmidt EB
Ugeskr Laeger; 2015 Aug; 177(36):. PubMed ID: 26324293
[TBL] [Abstract][Full Text] [Related]
14. Statin intolerance: an updated, narrative review mainly focusing on muscle adverse effects.
Li JJ; Liu HH; Wu NQ; Yeo KK; Tan K; Ako J; Krittayaphong R; Tan RS; Aylward PE; Baek SH; Dalal J; Fong AYY; Li YH; O'Brien RC; Lim TSE; Koh SYN; Scherer DJ; Tada H; Kang V; Butters J; Nicholls SJ
Expert Opin Drug Metab Toxicol; 2020 Sep; 16(9):837-851. PubMed ID: 32729743
[TBL] [Abstract][Full Text] [Related]
15. [Statin intolerance and statin-associated muscular pain].
Stürzebecher PE; Schumann F; Kassner U; Laufs U
Herz; 2022 Jun; 47(3):204-211. PubMed ID: 35451596
[TBL] [Abstract][Full Text] [Related]
16. Muscle and statins: from toxicity to the nocebo effect.
Pedro-Botet J; Climent E; Benaiges D
Expert Opin Drug Saf; 2019 Jul; 18(7):573-579. PubMed ID: 31070941
[TBL] [Abstract][Full Text] [Related]
17. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
Cziraky MJ; Watson KE; Talbert RL
J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
[TBL] [Abstract][Full Text] [Related]
18. Statin Intolerance: A Literature Review and Management Strategies.
Saxon DR; Eckel RH
Prog Cardiovasc Dis; 2016; 59(2):153-164. PubMed ID: 27497504
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of bempedoic acid added to ezetimibe in statin-intolerant patients with hypercholesterolemia: A randomized, placebo-controlled study.
Ballantyne CM; Banach M; Mancini GBJ; Lepor NE; Hanselman JC; Zhao X; Leiter LA
Atherosclerosis; 2018 Oct; 277():195-203. PubMed ID: 29910030
[TBL] [Abstract][Full Text] [Related]
20. Statin-Associated Muscle Disease: Advances in Diagnosis and Management.
Taylor BA; Thompson PD
Neurotherapeutics; 2018 Oct; 15(4):1006-1017. PubMed ID: 30251222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
